ClinicalThought


Share

Program Content

Activities

  • Melanoma Immunotherapy FAQ
    Experts Address Questions on the Use of Immunotherapy for Resectable and Unresectable Melanoma in Today’s Practice
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb